Antimicrobial resistance poses a significant global health challenge, with aminoglycoside phosphotransferases (APHs) contributing to antibiotic inactivation. Here, the authors employ fragment-based drug design to identify a promising APH inhibitor, enhancing bacterial sensitivity to aminoglycosides.
- Julien Kowalewski
- Robin Deutscher
- Corinne Lionne
